RXSTRxSight, Inc.Healthcare · Medical - Devicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $5.40 · now $5.40 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, RXST has typically landed between $4.14 and $6.88 — a range of −23.2% to +27.5% from the issuance price $5.40.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,267 overlapping 1 month windows · 2021-07-302026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($5.40) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where RXST has typically landed a month from the 2026-09-16 close of $5.4 — the range is history, not a prediction.

$4.14worst · -23.2%$6.88best · +27.5%
  • now $5.4 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $5.33 (-1.4%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $4.67$5.98
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $4.14$6.88
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,267 windows spanning 2021-07-30 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2025-06-10−49.0%−49.3%+0.0%
2025-06-13−48.8%−48.8%+0.0%
2025-06-11−48.1%−48.1%+0.0%
3 best
2022-05-09+55.1%+0.0%+55.1%
2023-11-13+53.7%+0.0%+53.7%
2025-11-05+51.4%+0.0%+51.4%

1,267 overlapping windows · 2021-07-302026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
40%
−0.7%
n=5
Feb
40%
+3.6%
n=5
Mar
20%
−4.1%
n=5
Apr
60%
−3.9%
n=5
May
80%
+7.8%
n=5
Jun
60%
−0.1%
n=5
Jul
60%
−3.5%
n=5
Aug
50%
+4.7%
n=6
Sep
0%
−10.8%
n=6
Oct
40%
−4.4%
n=5
Nov
60%
+10.4%
n=5
Dec
40%
+0.2%
n=5

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$13$52026-09-02: 4 insider sales, $118K — Wilterding Mark, Kurtz Ronald M MD, Goldshleger Ilya, Weinberg Eric2026-09: 4 open-market sales, $118K↑ buys↓ salesofficer Wilterding Mark — Sale on 2026-09-02, filed same daydirector Kurtz Ronald M MD — Sale on 2026-09-02, filed same dayofficer Goldshleger Ilya — Sale on 2026-09-02, filed same dayofficer Weinberg Eric — Sale on 2026-09-02, filed same day
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-09-02Wilterding MarkofficerSale7,765 @ $6.96$54K−23.7% of holdingnot yet — horizon still opennot yet — horizon still open25,049Form 4 · filed same day
2026-09-02Kurtz Ronald M MDdirectorSale5,100 @ $6.96$35K−6.6% of holdingnot yet — horizon still opennot yet — horizon still open71,775Form 4 · filed same day
2026-09-02Goldshleger IlyaofficerSale2,041 @ $6.96$14K−2.4% of holdingnot yet — horizon still opennot yet — horizon still open81,509Form 4 · filed same day
2026-09-02Weinberg EricofficerSale2,041 @ $6.96$14K−1.0% of holdingnot yet — horizon still opennot yet — horizon still open200,348Form 4 · filed same day
2025-03-12Fountain TamaradirectorSale7,000 @ $25.71$180K−22.0% of holding−39.7%−82.2%24,793Form 4 · filed 1 day after the trade
2025-01-22Maniar ShwetadirectorSale3,519 @ $30.87$109K−32.3% of holding−6.2%−80.4%7,383Form 4 · filed 5 days after the trade
2025-01-16Corley Jesse AndersondirectorPurchase1,767 @ $31.13$55K+122.5% of holding−4.6%−83.3%3,210Form 4 · filed 1 day after the trade
2025-01-15Corley Jesse AndersondirectorPurchase1,443 @ $31.18$45Kownership Δ n/a−7.7%−83.0%1,443Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

213 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-15Weinberg EricofficerOption exercise35,168235,516Form 4
2026-09-15Weinberg EricofficerOption exercise35,1680Form 4
2026-09-05Weinberg EricofficerAward / grant82,60882,608Form 4
2026-09-05Kurtz Ronald M MDdirectorDisposition149,0000Form 4
2026-09-05Kurtz Ronald M MDdirectorDisposition215,0000Form 4
2026-09-05Kurtz Ronald M MDdirectorAward / grant254,751254,751Form 4
2026-09-05Kurtz Ronald M MDdirectorAward / grant173,913173,913Form 4
2026-09-05Kurtz Ronald M MDdirectorAward / grant96,12996,129Form 4
2026-09-05Kurtz Ronald M MDdirectorAward / grant161,654161,654Form 4
2026-09-05Weinberg EricofficerDisposition87,4370Form 4
2026-09-05Weinberg EricofficerDisposition95,0000Form 4
2026-09-05Weinberg EricofficerDisposition92,2000Form 4
2026-09-05Weinberg EricofficerDisposition50,0000Form 4
2026-09-05Weinberg EricofficerDisposition125,0000Form 4
2026-09-05Weinberg EricofficerAward / grant65,74265,742Form 4
2026-09-05Weinberg EricofficerAward / grant82,60882,608Form 4
2026-09-05Weinberg EricofficerAward / grant59,48359,483Form 4
2026-09-05Weinberg EricofficerAward / grant32,25832,258Form 4
2026-09-05Weinberg EricofficerAward / grant93,98493,984Form 4
2026-09-05Wilterding MarkofficerDisposition258,7700Form 4
2026-09-05Wilterding MarkofficerAward / grant258,770258,770Form 4
2026-09-05Goldshleger IlyaofficerDisposition98,3670Form 4
2026-09-05Goldshleger IlyaofficerDisposition120,0000Form 4
2026-09-05Goldshleger IlyaofficerDisposition92,2000Form 4
2026-09-05Goldshleger IlyaofficerDisposition50,0000Form 4
2026-09-05Goldshleger IlyaofficerDisposition125,0000Form 4
2026-09-05Goldshleger IlyaofficerAward / grant73,96073,960Form 4
2026-09-05Goldshleger IlyaofficerAward / grant104,347104,347Form 4
2026-09-05Goldshleger IlyaofficerAward / grant59,48359,483Form 4
2026-09-05Goldshleger IlyaofficerAward / grant32,25832,258Form 4
2026-09-05Goldshleger IlyaofficerAward / grant93,98493,984Form 4
2026-09-05Wilterding MarkofficerDisposition258,7700Form 4
2026-09-05Wilterding MarkofficerAward / grant258,770258,770Form 4
2026-09-05Weinberg EricofficerDisposition87,4370Form 4
2026-09-05Weinberg EricofficerDisposition95,0000Form 4
2026-09-05Weinberg EricofficerDisposition92,2000Form 4
2026-09-05Weinberg EricofficerDisposition50,0000Form 4
2026-09-05Weinberg EricofficerDisposition125,0000Form 4
2026-09-05Weinberg EricofficerAward / grant65,74265,742Form 4
2026-09-05Weinberg EricofficerAward / grant82,60882,608Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.